Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,164,597
  • Shares Outstanding, K 78,860
  • Annual Sales, $ 4,010 K
  • Annual Income, $ -214,530 K
  • 60-Month Beta 0.68
  • Price/Sales 998.28
  • Price/Cash Flow N/A
  • Price/Book 4.34
Trade CRNX with:

Options Overview Details

View History
  • Implied Volatility 49.81% ( -6.44%)
  • Historical Volatility 47.99%
  • IV Percentile 2%
  • IV Rank 2.16%
  • IV High 258.85% on 09/06/23
  • IV Low 45.19% on 06/11/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 67
  • Volume Avg (30-Day) 452
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 10,051
  • Open Int (30-Day) 16,405

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.86
  • Number of Estimates 8
  • High Estimate -0.79
  • Low Estimate -0.92
  • Prior Year -0.94
  • Growth Rate Est. (year over year) +8.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
41.01 +30.87%
on 06/26/24
54.57 -1.65%
on 07/12/24
+5.89 (+12.33%)
since 06/12/24
3-Month
41.01 +30.87%
on 06/26/24
54.57 -1.65%
on 07/12/24
+9.08 (+20.36%)
since 04/12/24
52-Week
15.76 +240.55%
on 09/08/23
54.57 -1.65%
on 07/12/24
+33.70 (+168.75%)
since 07/12/23

Most Recent Stories

More News
Stocks Recover on Lower Bond Yields and Strength in Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.56%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.83%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.26%. Stocks on Tuesday...

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
^BTCUSD : 57,846.20 (+0.72%)
ZNU24 : 111-060s (+0.03%)
IP : 43.63 (+1.68%)
FUSN : 21.55 (+0.14%)
BKR : 34.50 (-0.03%)
APA : 29.97 (+0.60%)
International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall, Tuesday, 3/19/2024

Stocks that traded heavily or had substantial price changes on Tuesday: International Paper, Unilever rise; Super Micro, Freeport-McMoRan fall

SMCI : 909.96 (+2.33%)
IP : 43.63 (+1.68%)
CRNX : 53.67 (+1.63%)
AZN.LN : 12,268.155 (+1.39%)
AZN : 79.24 (+1.67%)
FUSN : 21.55 (+0.14%)
FCX : 51.28 (-0.45%)
UL : 57.61 (+1.73%)
ULVR.LN : 4,434.000 (+0.64%)
Stocks Rise in Afternoon Trade

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.41%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.32%. The broader market is higher...

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
^BTCUSD : 57,846.20 (+0.72%)
ZNU24 : 111-060s (+0.03%)
SMCI : 909.96 (+2.33%)
NVDA : 129.24 (+1.44%)
AMD : 181.61 (-0.18%)
MRVL : 73.59 (+1.95%)
Weakness in Chip Stocks Leads the Broader Market Lower

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.78%. Stocks this morning...

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
^BTCUSD : 57,846.20 (+0.72%)
ZNU24 : 111-060s (+0.03%)
SMCI : 909.96 (+2.33%)
NVDA : 129.24 (+1.44%)
AMD : 181.61 (-0.18%)
MRVL : 73.59 (+1.95%)
Young Adults and Pancreatic Cancer: What the 80% Rise in Diagnoses Means for Future Treatment

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GNLX),(NASDAQ:CRNX),(NYSE:PFE),(NASDAQ:SGEN) EQNX::TICKER_END

ONCY : 1.0400 (+1.96%)
ONC.TO : 1.44 (+2.86%)
GNLX : 2.35 (-7.84%)
CRNX : 53.67 (+1.63%)
PFE : 28.92 (+0.91%)
SGEN : 228.74 (-0.07%)
Navigating the Surge in Pancreatic Cancer: The Innovative Strategies Offering New Hope

USA News Group – Researchers are becoming increasingly concerned with the rates of cancer on the rise among people under 50. A recent study found a nearly 80% global increase in the number of under-50s...

ONCY : 1.0400 (+1.96%)
ONC.TO : 1.44 (+2.86%)
GNLX : 2.35 (-7.84%)
CRNX : 53.67 (+1.63%)
PFE : 28.92 (+0.91%)
SGEN : 228.74 (-0.07%)
Up 83% in 5 Days, Is Crinetics Pharmaceuticals a Buy?

Despite good results in phase 3 trials, there are barriers to its drug candidate's success.

CRNX : 53.67 (+1.63%)
Why Crinetics Pharmaceuticals Stock Soared This Week

A positive late-stage trial readout fueled a major rally in the drugmaker's shares.

CRNX : 53.67 (+1.63%)
Stocks Settle Higher as Tesla’s Surge Powers Gains in Tech Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.67%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.19%....

$SPX : 5,615.35 (+0.55%)
SPY : 559.99 (+0.63%)
$DOWI : 40,000.90 (+0.62%)
DIA : 400.32 (+0.68%)
$IUXX : 20,331.49 (+0.59%)
QQQ : 494.82 (+0.59%)
TSLA : 248.23 (+2.99%)
CVS : 59.00 (+1.36%)
QCOM : 202.43 (+1.29%)
MTB : 155.21 (+0.17%)
KVUE : 18.34 (+2.34%)
DXCM : 114.06 (+1.24%)
Why Shares of Crinetics Pharmaceuticals Are Jumping Monday

The biotech company reported positive phase 3 trial results.

CRNX : 53.67 (+1.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly,...

See More

Key Turning Points

3rd Resistance Point 56.61
2nd Resistance Point 55.59
1st Resistance Point 54.63
Last Price 53.67
1st Support Level 52.65
2nd Support Level 51.63
3rd Support Level 50.67

See More

52-Week High 54.57
Last Price 53.67
Fibonacci 61.8% 39.74
Fibonacci 50% 35.17
Fibonacci 38.2% 30.59
52-Week Low 15.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar